Latest
 
  • All Share : 52957.32
    DOWN -0.50%
    Top40 - (Tradeable) : 46471
    DOWN -0.69%
    Financial 15 : 15475.66
    DOWN -1.68%
    Industrial 25 : 69839.36
    DOWN -0.64%
    Resource 10 : 32203.24
    UP 0.56%

  • ZAR/USD : 14.6298
    UP 2.49%
    ZAR/GBP : 21.2255
    UP 1.58%
    ZAR/EUR : 16.8119
    UP 2.20%
    ZAR/JPY : 0.1362
    UP 1.95%
    ZAR/AUD : 10.9529
    UP 0.22%

  • Gold US$/oz : 1285.7
    DOWN -0.40%
    Platinum US$/oz : 1066
    DOWN -1.20%
    Silver US$/oz : 17.39
    DOWN -0.69%
    Palladium US$/oz : 605
    DOWN -2.42%
    Brent Crude : 45.22
    DOWN -1.44%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required